XIDX
SAME
Market cap303mUSD
Nov 12, Last price
316.00IDR
Name
Sarana Meditama Metropolitan Tbk PT
Chart & performance
P/E
180.35
P/S
2.91
EPS
1.75
Div yield, %
—
Shrs. gr., 5y
10.85%
Rev. gr., 5y
29.68%
Revenues
1.86t
+9.12%
Net income
30.08b
+153.83%
CFO
357.02b
+35.53%
Dividend
May 18, 20181.10638 IDR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating as a subsidiary of PT Elang Mahkota Teknologi Tbk, PT Sarana Meditama Metropolitan Tbk primarily manages EMC Hospital Pulomas, located in Pulomas, East Jakarta. This Indonesian company, established in 1984, maintains its headquarters in Jakarta.
Key people
President Director · since 2020
Vice President Director · since 2020
Nailufar Mars
Head of Sales & Marketing, Director · since 2020
Director · since 2020
G. A. Kusmiati Mars
Director · since 2020
Meta Dewi Thedja
Director · since 2020
Unggung Cahyono
Independent Commissioner · since 2020
President Commissioner and Independent Commissioner · since 2020
Marianna Sutadi
Independent Commissioner · since 2021
Headquarters & legal address
JL. PULOMAS BARAT VI NO. 20, KAYU PUTIH, PULOGADUNG
JAKARTA TIMUR
JAKARTA 13210
ID
JAKARTA TIMUR
JAKARTA 13210
ID
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||